These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 19800124

  • 1. Modelling of the membrane receptor CXCR3 and its complexes with CXCL9, CXCL10 and CXCL11 chemokines: putative target for new drug design.
    Trotta T, Costantini S, Colonna G.
    Mol Immunol; 2009 Dec; 47(2-3):332-9. PubMed ID: 19800124
    [Abstract] [Full Text] [Related]

  • 2. The N-terminal region of CXCL11 as structural template for CXCR3 molecular recognition: synthesis, conformational analysis, and binding studies.
    Palladino P, Portella L, Colonna G, Raucci R, Saviano G, Rossi F, Napolitano M, Scala S, Castello G, Costantini S.
    Chem Biol Drug Des; 2012 Aug; 80(2):254-65. PubMed ID: 22531000
    [Abstract] [Full Text] [Related]

  • 3. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation.
    Xanthou G, Williams TJ, Pease JE.
    Eur J Immunol; 2003 Oct; 33(10):2927-36. PubMed ID: 14515277
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
    Heise CE, Pahuja A, Hudson SC, Mistry MS, Putnam AL, Gross MM, Gottlieb PA, Wade WS, Kiankarimi M, Schwarz D, Crowe P, Zlotnik A, Alleva DG.
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F, Zimmermann HW, Berres ML, Trautwein C, Wasmuth HE.
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [Abstract] [Full Text] [Related]

  • 9. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.
    Helbig KJ, Ruszkiewicz A, Lanford RE, Berzsenyi MD, Harley HA, McColl SR, Beard MR.
    J Virol; 2009 Jan; 83(2):836-46. PubMed ID: 18987152
    [Abstract] [Full Text] [Related]

  • 10. Dual specificity of anti-CXCL10-CXCL9 antibodies is governed by structural mimicry.
    Fagète S, Rousseau F, Magistrelli G, Gueneau F, Ravn U, Kosco-Vilbois MH, Fischer N.
    J Biol Chem; 2012 Jan 06; 287(2):1458-67. PubMed ID: 22041899
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
    Lasagni L, Francalanci M, Annunziato F, Lazzeri E, Giannini S, Cosmi L, Sagrinati C, Mazzinghi B, Orlando C, Maggi E, Marra F, Romagnani S, Serio M, Romagnani P.
    J Exp Med; 2003 Jun 02; 197(11):1537-49. PubMed ID: 12782716
    [Abstract] [Full Text] [Related]

  • 13. Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease.
    Kao J, Kobashigawa J, Fishbein MC, MacLellan WR, Burdick MD, Belperio JA, Strieter RM.
    Circulation; 2003 Apr 22; 107(15):1958-61. PubMed ID: 12695288
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.
    Kawada K, Sonoshita M, Sakashita H, Takabayashi A, Yamaoka Y, Manabe T, Inaba K, Minato N, Oshima M, Taketo MM.
    Cancer Res; 2004 Jun 01; 64(11):4010-7. PubMed ID: 15173015
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function.
    Colvin RA, Campanella GS, Sun J, Luster AD.
    J Biol Chem; 2004 Jul 16; 279(29):30219-27. PubMed ID: 15150261
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
    Karin N.
    Front Immunol; 2020 Jul 16; 11():976. PubMed ID: 32547545
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.